Trailing Twelve Months Revenue Growth: Corbus Pharmaceuticals, Inc. (CRBP)

Public company logo of corbuspharma.com (CRBP)

ADC-conjugate patents and stringent FDA oversight create insurmountable barriers for competitors. This TTM year-over-year revenue chart on GURU.Markets shows that 0.00 serves as the current metric level for Corbus Pharmaceuticals (CRBP). Business efficiency is sustained by outsourcing trials to external contractors, while the diversification of international antibody supply chains ensures stable margins and protection against raw material shortages.

Corbus Pharmaceuticals (CRBP): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Corbus Pharmaceuticals - analytical breakdowns and key metrics (CRBP)

- company stock exchange capitalization indicators:
Summary company analytics:Corbus Pharma
Brand item of Corbus Pharmaceuticals, Inc.

To identify fundamental leaders within the analytics sector, it is essential to track revenue dynamics, which determine business viability during periods of market volatility. This indicator measures the percentage change in sales volume over a rolling year, allowing for an assessment of the commercial success of Corbus Pharmaceuticals (CRBP) and its CRB-701 drug, as well as the selectivity of ADC technologies, through the lens of year-over-year sales growth over the last 12 months.

Who Corbus Pharmaceuticals competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CHRS (Coherus BioSciences)|Cardiff Oncology - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)